MRCP+ FDA clearance

Life with Primary Sclerosing Cholangitis
1

This sounds interesting. Hopefully soon available in US liver clinics.

FDA Clears Perspectum’s MRCP+ Digital Biliary Tree Viewer

First quantitative AI tool for biliary disease enables quantitative and objective assessment of the bile ducts for the first time

January 24, 2019 — Perspectum Diagnostics received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its MRCP+ advanced biliary visualization software.

Perspectum has developed quantitative [magnetic resonance imaging (MRI) and [artificial intelligence (AI)] algorithms for magnetic resonance cholangiopancreatography (MRCP) images to provide improved visualization of intra-hepatic ducts, and measure the widths of bile ducts, biliary tree volume and gallbladder volume. Combining image viewing, processing and reporting tools, the metrics provided are designed to support physicians in the visualization, evaluation, monitoring and reporting of hepatobiliary structures. This is especially relevant for serial evaluation in primary sclerosing cholangitis (PSC) patients…

2 Likes
2

Thank you for sharing!

3

Ted,
Thanks for sharing this news. This is really quite fascinating to me. I sent the link to the article to one of my doctors at Duke Medical Center. I hope it will be a great asset to more clearly define strictures, etc. in the biliary tree for PSC patients.

Mark

4

That’s great news. Thanks very much for sharing.

Daniela

5

Interesting

6

I asked one of my hepatologist’s at Duke about this technology. For what its worth here was his response…

We have had this for research purposes. The first version is not as great as we would like but I hope it progresses.

Mark